Resistant Hypertension is a form of high blood pressure that does not
respond adequately to conventional treatments.
Resistant Hypertension Clinical Study
Despite medications, lifestyle changes, and interventions, some patients continue to experience high blood pressure levels. Around 20-30% of individuals with hypertension may have resistant forms of the condition. The patients face increased risk of cardiovascular conditions.
Koch Research initiated a randomized, parallel study design that studied an investigational drug that inhibits aldosterone synthase and improves blood flow. We discovered a potent therapy for treatment-resistant hypertension which ultimately manages the hypertension condition.
Current Status
Inactive
Total Studies
01
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.
